Global Reorganization of Replication Domains During Embryonic Stem Cell Differentiation

Ichiro Hiratani, Tyrone Ryba, Mari Itoh, +7

PLoS Biology

GeneticsStem Cell DifferentiationCell CycleCell DifferentiationStem Cell Biology +18

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, +24

Nature Medicine

Machine Learning–Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival

Richard Li, Ashwin Shinde, An Liu, +5

JCO Clinical Cancer Informatics

Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer

Stephanie Sprowl‐Tanio, Amber N. Habowski, Kira T. Pate, +6

Cancer & Metabolism

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Nazlı Dizman, Yung Lyou, Nicholas Salgia, +7

Journal for ImmunoTherapy of Cancer

Generation of Functional Eyes from Pluripotent Cells

Andrea S. Viczian, Eduardo Solessio, Yung Lyou, +1

PLoS Biology

Retinal CellsEmbryonic Stem CellGanglion CellFunctional EyesDevelopmental Biology +13

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

Sumanta K. Pal, Paul Frankel, Amir Mortazavi, +17

JAMA Oncology

Maturin is a novel protein required for differentiation during primary neurogenesis

Reyna I. Martinez‐De Luna, Ray Yueh Ku, Yung Lyou, +1

Developmental Biology

Novel ProteinNeuroregenerationDevelopmental BiologyPrimary NeurogenesisNeurogenesis +6

Disruption of β-Catenin–Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion

George Chen, Delia F. Tifrea, Rabi Murad, +7

Molecular Cancer Research

Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1–3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3–altered Advanced/Metastatic Urothelial Carcinoma

Yung Lyou, Petros Grivas, Jonathan E. Rosenberg, +16

European Urology

UrologyHyperphosphatemia SecondaryGenitourinary CancerAdvanced/metastatic Urothelial CarcinomaCancer Growth +7